Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries

Circulation

Volumn 93, Issue 6, 1996, Pages 1201-1205

  Maalej, Nabil ^a   Folts, John D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

aspirin; stenosis; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; DOG; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0029917453     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.6.1201     Document Type: Article

References (25)

1. Davies MJ, Fulton VFM, Robertson WB. The relation of coronary thrombosis to ischemic myocardial necrosis. J Pathol. 1979;127: 99-110.
2. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981; 304:685-691.
3. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:310-318.
4. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.
5. Folts JD. A model of experimental arterial platelet thrombosis, platelet inhibitors, and their possible clinical relevance: an update. Cardiovasc Rev Rep. 1990;11:10-26.
6. Folts JD. An in vivo model of experimental stenosis, intimal damage, and periodic thrombosis. Circulation. 1991;83(suppl IV): IV-3-IV-14.
7. Aiken JW, Shebuski RJ, Miller OV, Gorman RR. Endogenous prostracyclin contributes to the efficacy of thromboxane synthesis inhibitor for preventing coronary artery thrombosis. J Pharmacol Exp Ther. 1981;219:299-308.
8. Bush L, Campbell WB, Buja LM, Tilton GD, Willerson JT. Effect of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Circulation. 1984;69:1161-1170.
9. 2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses. Circulation. 1987;76:952-959.
10. Ashton JH, Benedict CR, Fitzgerald C, Raheja S, Taylor A, Campbell WB, Buja LM, Willerson JT. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation. 1986;73:572-578.
11. 2 receptor antagonist retanserin. Cardiovasc Res. 1990; 26:465-470.
12. Yao SK, Ober JC, McNatt J, Benedict CR, Rosolowsky M, Anderson HV, Cui K, Maffrand JP, Campbell WB, Buja LM, Willerson JT. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Circ Res. 1992;70: 39-48.
13. Khouri EM, Gregg DE, McGranaham GM. Regression and reappearance of coronary collaterals. Am J Physiol. 1971;220:655-661.
14. Weber DM, Molloi SY, Folts JD, Peppler WW, Mistretta CM. Absolute diameter measurements of coronary arteries based on the first zero crossing of the Fourier spectrum. Med Phys. 1989;16: 188-196.
15. Goldsmith HL, Turitto VT. Rheological aspects of thrombosis and haemostasis: basic principles and applications. Thromb Haemost. 1986;55:415-435.
16. Dinnar U. Properties of flowing blood. In: Dinnar U, ed. Cardiovascular Fluid Dynamics. Boca Raton, Fla: CRC Press, Inc; 1981: 23-54.
17. Coller BS. Platelets in cardiovascular thrombosis and thrombolysis. In: Fozzard et al, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1992:219-273.
18. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994;330: 1287-1294.
19. Folts JD. Drugs for the prevention of coronary thrombosis: from animal model to clinical trials. J Cardiovasc Drugs Ther. 1995;9: 31-43.
20. O'Brien JR. Shear induced platelet aggregalion. Lancet. 1990;335: 711-713.
21. Stevens DE, Joist JH, Suters SP. Role of platelet prostaglandin synthesis in shear induced platelet alterations. Blood. 1987;70: 1354-1361.
22. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-120.
23. Coller BS, Folts JD, Scudder LE, Smith SR. Antithrombotic effect of monoclonal antibodies to the platelet GPIIb/IIIa receptor in an experimental animal model. Blood. 1986;68:783-786.
24. Coller BS, Smith SR, Scudder LE, Jordan R, Folts JD. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor: correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors. Circulation. 1989;80:1766-1774.
25. FLUENT Reference Manual. Hanover, NH: Creare Inc; 1992.